Small decreases in HbA1c, BP could lower CVD risk in type 2 diabetes

10/6/2011 | InternalMedicineNews.com (free registration)

A Dutch study presented at the annual meeting of the European Society for the Study of Diabetes estimated that a 0.5% decrease in hemoglobin A1c levels and a 10 Hg/mm decrease in systolic blood pressure could help reduce the risks of heart attack, stroke and other cardiovascular complications in type 2 diabetes patients by 10% over five years.

View Full Article in:

InternalMedicineNews.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI